Trial intelligence / Profile preview

Buspirone in Functional Dysphagia

NCT02674412Completed

Sponsor
Cleveland Clinic
Start
Feb 2016
Primary completion
Apr 2017
Modality
Small Molecules
01

Overview

Randomised, double-blind trial of buspirone in Functional dysphagia (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Distal Contractile Index at 14 days. Started Feb 2016; status: completed.

02

Drugs

buspirone
03

Conditions

Functional dysphagia

Beyond the preview

Go deeper on NCT02674412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02674412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call